Kailian Medical Technology's Touchscreen Insulin Pump Seeks EU and Southeast Asia Overseas Partners
Purchaser Advantages: Kailian Medical Technology (Shanghai) Co., Ltd. was established in 2014, focusing on micro-infusion technology and a mobile internet cloud management platform to provide lifecycle solutions for patients with chronic diseases such as diabetes. Its flagship product is China’s first fully touch-screen operated insulin pump, with an infusion accuracy of 0.01U/hour, exclusively promoted in partnership with Inbida. The product incorporates touch interaction and fingerprint unlocking technology to simplify operation and enhance safety. The company is currently seeking overseas partners in the EU and Southeast Asia.
| Published by | Kailian Medical | Department | -- |
|---|---|---|---|
| Region | Shanghai,China | Budget | -- |
| Validity | Long-term | ||
1. Company Introduction
Kailian Medical Technology (Shanghai) Co., Ltd. was established in 2014. Relying on a research and development technical team and market operation service team with over 15 years of experience, the company combines its proprietary micro-infusion product technology with a mobile Internet cloud management platform based on hardware development to provide comprehensive lifecycle solutions for patients related to diabetes, endocrine chronic diseases, and infertility—from diagnosis and treatment to care.
2. Product Introduction: Touchscreen Insulin Pump
This product is the first insulin pump in China to feature full touch-screen operation, breaking the monopoly of overseas brands on touch-screen insulin pumps. With an infusion accuracy of 0.01U/hour, it sets a new standard for insulin delivery system control. Currently, Kailian Medical Technology (Shanghai) Co., Ltd. has reached an exclusive cooperation agreement with the well-known, century-old listed company InBetta for the promotion of this product among customers in mainland China.
This product abandons the operation method of mechanical buttons and the menu design of up to 5 levels commonly found in insulin pump products. It introduces a touch interaction method and optimizes the UI design to make the operation settings simpler and more intuitive. Moreover, the product also applies fingerprint unlocking to ensure the security of use.
3. Requirements Description
Seeking EU and Southeast Asia overseas partners, interested parties are welcome to communicate.